Sonic Hedgehog Pathway as a Target for Therapy in Angiogenesis-Related Diseases by C. Porro et al.
Sonic Hedgehog Pathway as a Target for Therapy in
Angiogenesis-Related Diseases
Submitted by Emmanuel Lemoine on Wed, 12/11/2013 - 17:08
Titre Sonic Hedgehog Pathway as a Target for Therapy in Angiogenesis-Related Diseases
Type de
publication Article de revue
Auteur Porro, Chiara [1], Soleti, Raffaella [2], Benameur, Tarek [3], Maffione, Angela B. [4],Andriantsitohaina, Ramaroson [5], Martinez, Maria Carmen [6]
Editeur Bentham Science Publishers
Type Article scientifique dans une revue à comité de lecture
Année 2009
Date 2009
Numéro 1
Pagination 31 - 45
Volume 4
Titre de la
revue Current Signal Transduction Therapy
ISSN 1574-3624
Résumé en
anglais
Hedgehog (Hh) proteins belong to a class of morphogens involved in many biological
processes during embryonic development; they are relatively silent during normal
adult life although they may be recruited postnatally in response to tissue injury.
Three secreted proteins have been identified: Sonic hedgehog (Shh), Desert
hedgehog and Indian hedgehog. The interaction of Hh ligand with its receptor
Patched-1 triggers the activation of smoothened and initiates transduction events
that lead to the regulation of transcriptional factors belonging to the Gli family. Hh
pathway orchestrates both coronary development and adult coronary
neovascularisation by controlling the expression of multiple proangiogenic genes
and anti-apoptotic cytokines. Shh pathway enhances the recruitment of endothelial
progenitor cells in addition to the mechanisms described for other Hh and concurs
to its myocardial protection. In cerebral ischemia, Hh mimicking molecules has been
reported to limit damages caused by vessel occlusion. Besides, Shh carried by
microparticles corrects endothelial injury through nitric oxide release. Anomalous
activations of Hh pathway are implicated in various types of tumours including
medulloblastoma, carcinoma of esophagus, stomach, pancreas and colon. Hh can
influence angiogenesis in both positive and negative manner and they may have
implication for therapeutic strategies to treat either ischemic or cancer diseases.
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